More than a decade after the Drug Quality and Security Act (DQSA) of 2013 created the 503B category, the central question ...

Add Yahoo as a preferred source to see more of our stories on Google. Patients have been buying compounded weight loss drugs at lower prices than brand-name medications amid shortages of tirzepatide ...

When endocrinologist Dan Bessesen, MD, looked online and saw how easy it would be for him to purchase a weight loss drug from a compounding pharmacy without being seen by a medical provider, he was ...

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes and more recently for obesity and other labeled and ...

The roughly $1,000 monthly price tag of Eli Lilly's weight loss drug Zepbound put the blockbuster treatment out of reach for Willow Baillies, 29, whose insurance does not cover it. Baillies, a human ...

Agnes Juang, Ph.D., Makoto Tsunozaki Ph.D. In an attempt to prevent compounding of its drug products, Novo Nordisk has taken action against compounding pharmacies under federal trademark as well as ...

Empower Pharmacy markets itself as a well-meaning rival to Big Pharma — one that seeks to democratize medicine by making affordable, personalized drugs for patients who need them. As one of an ...

Strive Compounding Pharmacy sues Eli Lilly and Novo Nordisk over alleged GLP-1 weight loss drug competition limits. Read more here.

The repeat problems at Houston-based Empower Pharmacy include inadequate quality testing and a failure to clean equipment.

In an effort to prevent disease outbreaks similar to the cases of meningitis caused by the New England Compounding Center in October 2012, the Massachusetts House of Representatives unanimously voted ...